Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Leases: 2019-2025

Historic Current Leases for CorMedix (CRMD) over the last 5 years, with Sep 2025 value amounting to $844,431.

  • CorMedix's Current Leases rose 416.63% to $844,431 in Q3 2025 from the same period last year, while for Sep 2025 it was $844,431, marking a year-over-year increase of 416.63%. This contributed to the annual value of $167,922 for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Current Leases stood at $844,431 for Q3 2025, which was up 376.62% from $177,172 recorded in Q2 2025.
  • CorMedix's 5-year Current Leases high stood at $844,431 for Q3 2025, and its period low was $112,323 during Q1 2021.
  • Moreover, its 3-year median value for Current Leases was $161,263 (2024), whereas its average is $226,723.
  • Data for CorMedix's Current Leases shows a peak YoY spiked of 416.63% (in 2025) over the last 5 years.
  • CorMedix's Current Leases (Quarterly) stood at $121,368 in 2021, then increased by 11.23% to $135,000 in 2022, then grew by 11.80% to $146,531 in 2023, then climbed by 11.55% to $167,922 in 2024, then skyrocketed by 416.63% to $844,431 in 2025.
  • Its Current Leases was $844,431 in Q3 2025, compared to $177,172 in Q2 2025 and $172,495 in Q1 2025.